MeSH term
Frequency | Condition_Probility | Chromosome Aberrations | 3 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Humans | 54 | 0.0 |
Nucleic Acid Hybridization | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Oncogenes | 3 | 1.0 |
Polymerase Chain Reaction | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Comparative Study | 9 | 0.0 |
Gene Amplification/*genetics | 3 | 2.0 |
Sarcoma/*genetics | 3 | 8.0 |
Animals | 22 | 0.0 |
Binding Sites | 3 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Transcription Factors/*metabolism | 5 | 0.0 |
Base Sequence | 5 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
Male | 25 | 0.0 |
Rats | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 17 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Trans-Activators/genetics/*metabolism | 4 | 1.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
Brain Neoplasms/*genetics | 4 | 2.0 |
Cell Line | 5 | 0.0 |
*Gene Amplification | 6 | 1.0 |
Glioblastoma/*genetics | 3 | 4.0 |
*Oncogenes | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Gene Expression | 2 | 0.0 |
Mice | 16 | 0.0 |
*Nerve Tissue Proteins | 5 | 1.0 |
*Repressor Proteins | 4 | 0.0 |
Signal Transduction/drug effects/physiology | 2 | 0.0 |
Transfection | 2 | 0.0 |
*Xenopus Proteins | 4 | 1.0 |
Child, Preschool | 6 | 0.0 |
*Chromosomes, Human, Pair 12 | 8 | 2.0 |
Female | 22 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Chick Embryo | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Stem Cells/cytology/metabolism | 2 | 4.0 |
Adult | 17 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Drosophila | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Fetus | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 4 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Oncogene Proteins/*metabolism | 2 | 2.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Aged | 10 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Gene Amplification | 3 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Middle Aged | 18 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Oncogene Proteins/biosynthesis/*genetics | 2 | 18.0 |
Transcription Factors/biosynthesis/*genetics | 2 | 1.0 |
Translocation, Genetic | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Signal Transduction | 4 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
*Zinc Fingers | 2 | 0.0 |
Blotting, Southern | 6 | 0.0 |
Mice, Transgenic | 3 | 0.0 |
Phenotype | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Mutation | 3 | 0.0 |
Up-Regulation | 3 | 0.0 |
Adolescent | 4 | 0.0 |
Child | 5 | 0.0 |
Models, Genetic | 2 | 0.0 |
Time Factors | 4 | 0.0 |
*Translocation, Genetic | 2 | 0.0 |
Body Patterning/*genetics | 2 | 10.0 |
Protein Binding | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
*Trans-Activators | 2 | 0.0 |
*Chromosome Mapping | 4 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Oncogene Proteins/*biosynthesis | 2 | 11.0 |
Protein Biosynthesis | 2 | 0.0 |
Transcription Factors/*biosynthesis | 2 | 1.0 |
Transcription, Genetic | 3 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Chromosomes, Human, Pair 12 | 3 | 1.0 |
Glioma/*genetics | 2 | 2.0 |
Mice, Nude | 2 | 0.0 |
Infant | 4 | 0.0 |
Gene Amplification/genetics | 3 | 5.0 |
Gene Deletion | 2 | 0.0 |
DNA, Neoplasm/genetics/isolation & purification | 2 | 1.0 |
Gene Rearrangement/genetics | 2 | 4.0 |
*Genetic Markers | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
DNA Probes | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Glucose Tolerance Test | 4 | 0.0 |
Peptides/*blood | 2 | 2.0 |
Glucagon/*blood | 2 | 11.0 |
*Glucose Tolerance Test | 2 | 3.0 |
Radioimmunoassay | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Blood Glucose/analysis | 2 | 0.0 |
Fasting | 3 | 0.0 |
Glucagon/blood | 2 | 2.0 |
Glucose/diagnostic use | 2 | 14.0 |
Blood Glucose/metabolism | 5 | 0.0 |
Dogs | 2 | 0.0 |
Gastrointestinal Hormones/*secretion | 2 | 5.0 |
Insulin/blood | 3 | 0.0 |
Antigens | 3 | 3.0 |
Arginine/diagnostic use | 2 | 7.0 |
Glucagon/*blood/immunology | 3 | 100.0 |
*Pancreatectomy | 2 | 22.0 |
Gastrectomy | 3 | 5.0 |
Glucose/*metabolism | 2 | 1.0 |
